CONFIRMing single-drug immune checkpoint blockade efficacy in mesothelioma

被引：0
|
作者：
Nowak, Anna K. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Western Australia, Natl Ctr Asbestos Related Dis, Crawley, WA 6009, Australia
[2] Univ Western Australia, Med Sch, Crawley, WA 6009, Australia
[3] Inst Resp Hlth, Nedlands, WA, Australia
[4] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA, Australia
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 11期
关键词：
OPEN-LABEL; MULTICENTER; SAFETY;
D O I：
10.1016/S1470-2045(21)00516-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1485 / 1487
页数：3
相关论文
共 50 条
  • [1] Immune Checkpoint Blockade in Malignant Mesothelioma
    Calabro, Luana
    Maio, Michele
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (03) : 418 - 422
  • [2] Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
    Harber, James
    Kamata, Tamihiro
    Pritchard, Catrin
    Fennell, Dean
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [3] Combination immune checkpoint blockade as an effective therapy for mesothelioma
    Fisher, S.
    Solin, J.
    Casey, T.
    Lesterhuis, W. J.
    Lansley, S.
    Robinson, B. W. S.
    Lake, R.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 230 - 230
  • [4] Combination immune checkpoint blockade as an effective therapy for mesothelioma
    Fear, Vanessa S.
    Tilsed, Caitlin
    Chee, Jonathan
    Forbes, Catherine A.
    Casey, Thomas
    Solin, Jessica N.
    Lansley, Sally M.
    Lesterhuis, W. Joost
    Dick, Ian M.
    Nowak, Anna K.
    Robinson, Bruce W.
    Lake, Richard A.
    Fisher, Scott A.
    [J]. ONCOIMMUNOLOGY, 2018, 7 (10):
  • [5] Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge
    Luana Calabrò
    Aldo Morra
    Robin Cornelissen
    Joachim Aerts
    Michele Maio
    [J]. Cancer Immunology, Immunotherapy, 2018, 67 : 1317 - 1324
  • [6] Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge
    Calabro, Luana
    Morra, Aldo
    Cornelissen, Robin
    Aerts, Joachim
    Maio, Michele
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1317 - 1324
  • [7] The impact of microbiota on the efficacy of immune checkpoint blockade
    Duong, C.
    Vetizou, M.
    Zitvogel, L.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 193 - 194
  • [8] Combined Immune Checkpoint Blockade in Mesothelioma: In Vivo Investigation of in Vitro Data
    Marcq, E.
    Van Audenaerde, J.
    De Waele, J.
    Jacobs, J.
    Van Loenhout, J.
    Pauwels, P.
    Smits, E.
    Van Meerbeeck, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S725 - S725
  • [9] Dissecting tumour-immune interactions in mesothelioma for identifying responders to immune checkpoint blockade
    Addala, V.
    Sneddon, S.
    Dick, I.
    Fennell, D.
    Pearson, J. V.
    Robinson, B.
    Creaney, J.
    Patch, A-M.
    Waddell, N.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1453 - S1453
  • [10] MCT4 blockade increases the efficacy of immune checkpoint blockade
    Babl, Nathalie
    Decking, Sonja-Maria
    Voll, Florian
    Althammer, Michael
    Sala-Hojman, Ada
    Ferretti, Roberta
    Korf, Clarissa
    Schmidl, Christian
    Schmidleithner, Lisa
    Nerb, Benedikt
    Matos, Carina
    Koehl, Gudrun E.
    Siska, Peter
    Bruss, Christina
    Kellermeier, Fabian
    Dettmer, Katja
    Oefner, Peter J.
    Wichland, Marvin
    Ugele, Ines
    Bohr, Christopher
    Herr, Wolfgang
    Ramaswamy, Shivapriya
    Heinrich, Timo
    Herhaus, Christian
    Kreutz, Marina
    Renner, Kathrin
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
12345